Presidential Document2023-24497
National Diabetes Month, 2023
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 3, 2023
Signed
October 31, 2023
Issuing agencies
Executive Office of the President
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 212 (Friday, November 3, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 212 (Friday, November 3, 2023)]
[Presidential Documents]
[Pages 75457-75459]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-24497]
Presidential Documents
Federal Register / Vol. 88, No. 212 / Friday, November 3, 2023 /
Presidential Documents
[[Page 75457]]
Proclamation 10663 of October 31, 2023
National Diabetes Month, 2023
By the President of the United States of America
A Proclamation
One in ten Americans has diabetes, and of that group,
one in five of them do not know that they do. While
this chronic condition is becoming more common, there
is so much that we can do to help prevent and manage
it. During National Diabetes Month, we recommit as a
Nation to making treatment more affordable, improving
care, and finally finding a cure.
Every day, millions of Americans with diabetes struggle
to afford life-saving insulin. It costs drug companies
just $10 a vial to produce, but some charge more than
30 times that amount. Americans across the country have
told me how those high prices sometimes force them to
ration their medication, too often resulting in
dangerous health complications that could have been
avoided. Too many of them know what it is like to lay
awake at night, staring at the ceiling, wondering how
to choose between putting food on the table and buying
the insulin they need to stay alive. It is wrong.
I ran for President to rebuild the middle class--and
that includes working to make health care a right in
this country, not a privilege. For decades, big
pharmaceutical companies have blocked efforts to lower
prescription drug costs, but together, we took them on
and won. Last year, I signed the Inflation Reduction
Act, one of the most significant laws ever passed to
reduce prescription drug prices, capping insulin at $35
per month for seniors on Medicare, down from as much as
$400 per month. The Inflation Reduction Act finally
gave Medicare the ability to negotiate for lower drug
prices, starting this year with ten drugs--including
treatments for diabetes--benefiting more than nine
million Americans. The law also requires drug companies
that raise prices faster than inflation to pay the
difference back to the Government, saving seniors up to
$618 per dose of medication. Seniors and other Part D
enrollees with high drug spending will have their out-
of-pocket drug costs capped at about $3,500 next year.
In 2025, the Inflation Reduction Act will cap total
out-of-pocket drug costs for all seniors on Medicare at
$2,000 per year, period. There is more to do, but these
steps will put money back in the pockets of millions of
families, easing fears and giving them just a little
more breathing room.
While we keep working to make diabetes medications more
affordable, my Administration is also focused on
prevention, early interventions, improving treatments,
and finding a cure. Today, one in three American adults
has prediabetes, with a risk of developing Type 2
diabetes within 5 years. Diabetes has serious
consequences. It is a leading cause of death in the
United States, and once diagnosed, increases one's risk
of heart attack, stroke, blindness, kidney failure, and
loss of toes, feet, or legs. It is important to be
aware of diabetes risk factors, many of which relate to
nutrition and physical activity deficits. To learn more
about risk factors and how to combat prediabetes, visit
the Centers for Disease Control and Prevention National
Diabetes Prevention Program: <a href="https://www.cdc.gov/diabetes/prevention/index.html">https://www.cdc.gov/diabetes/prevention/index.html</a>.
[[Page 75458]]
Last year, we launched the Advanced Research Project
Agency for Health (ARPA-H) to drive breakthroughs in
preventing, detecting, and treating deadly diseases,
including diabetes. Research advances have already
helped develop several new diabetes drugs, including
the first that can delay the onset of Type 1 diabetes,
giving recently diagnosed people more time before
starting insulin. This year, the Food and Drug
Administration also approved the first cell therapy for
adults with Type 1 diabetes who cannot safely manage
their glucose levels with insulin as well as the first
new oral medication for children with Type 2 diabetes
in over two decades. We remain committed to robust
research investment and to providing pathways to drive
the development and delivery of additional, effective
treatments and much-needed cures.
At the same time, we have expanded health coverage
nationwide and lowered health care costs for millions
of Americans, including the nearly 15 million Americans
who buy their coverage under the Affordable Care Act
and are saving $800 per year on their premiums. We are
also cracking down on surprise medical bills and junk
health insurance plans that look affordable but then
stick consumers with big hidden costs. Last year, we
held the first White House Conference on Hunger,
Nutrition, and Health in over 50 years where we
convened advocates, health care providers, food
companies, and officials from every level of
government. We have laid out a vision to prevent and
reduce the pervasiveness of diet-related disease, like
diabetes, across the United States by 2030, outlining a
comprehensive strategy to end hunger and put healthy
food on the table. Our plan incorporates steps to
better prevent and manage diabetes, including by
expanding access to nutrition counseling and working
with the Congress to make the Medicare Diabetes
Prevention Program permanent.
We want all 37 million Americans with diabetes to know
that we have their backs and that the historic progress
we have made to lower insulin prices is just the first
step. This month, we celebrate the courage and
resilience of this community; and we honor the medical
professionals, loved ones, and advocates who do so much
to help support it and keep driving us toward a cure.
NOW, THEREFORE, I, JOSEPH R. BIDEN JR., President of
the United States of America, by virtue of the
authority vested in me by the Constitution and the laws
of the United States, do hereby proclaim the month of
November 2023 as National Diabetes Month. I call upon
all Americans, school systems, government agencies,
nonprofit organizations, health care providers,
research institutions, and other interested groups to
join in activities that raise diabetes awareness and
help prevent, treat, and manage this disease.
[[Page 75459]]
IN WITNESS WHEREOF, I have hereunto set my hand this
thirty-first day of October, in the year of our Lord
two thousand twenty-three, and of the Independence of
the United States of America the two hundred and forty-
eighth.
<GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT>
(Presidential Sig.)
[FR Doc. 2023-24497
Filed 11-2-23; 8:45 am]
Billing code 3395-F4-P
</pre></body>
</html>Indexed from Federal Register on November 3, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.